SCHEDULE: FMR LLC Discloses 7.5% Stake in Lantheus Holdings

FMR LLC and Abigail P. Johnson have disclosed a beneficial ownership of 7.5% in Lantheus Holdings Inc., totaling 5,223,735.50 common shares.

Summary

• FMR LLC and Abigail P. Johnson reported beneficial ownership of 5,223,735.50 shares of Lantheus Holdings Inc. common stock.
• This represents 7.5% of the total outstanding common stock of Lantheus Holdings Inc.
• FMR LLC, classified as a parent holding company, holds sole voting power over 5,218,300.93 shares and sole dispositive power over 5,223,735.50 shares.
• Abigail P. Johnson, an individual, holds sole dispositive power over 5,223,735.50 shares, with no sole or shared voting power directly attributed.
• The filing was made under Rule 13d-1(b), indicating that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Several FMR LLC subsidiaries, including Fidelity Management & Research Company LLC, are identified as entities beneficially owning shares, with Fidelity Management & Research Company LLC owning 5% or greater.
• The Johnson family, including Abigail P. Johnson, are predominant owners of FMR LLC's Series B voting common shares, representing 49% of voting power, and may be deemed a controlling group.

Sentiment

Score: 6

Explanation: The disclosure of a significant 7.5% beneficial ownership by a major institutional investor like FMR LLC can be interpreted as a positive signal, indicating confidence in the issuer's long-term prospects. However, the filing itself is purely a compliance document and does not contain performance-related information.

Positives

• A significant institutional investor, FMR LLC, has disclosed a substantial 7.5% stake, which can be viewed as a vote of confidence in Lantheus Holdings Inc.
• The filing indicates the shares were acquired and are held in the ordinary course of business, not for control purposes, suggesting a passive investment intent.

Future Outlook

NA

Industry Context

This filing indicates continued institutional interest in the healthcare and medical diagnostics sector, specifically in companies like Lantheus Holdings Inc. Large investment firms like FMR LLC frequently adjust their portfolios based on market trends and company performance.

Comparison to Industry Standards

• The 7.5% stake is a significant position for an institutional investor, indicating a notable allocation within FMR LLC's portfolio for Lantheus Holdings Inc.
• Such disclosures are standard practice for institutional investors crossing the 5% beneficial ownership threshold, aligning with SEC regulations for transparency in public markets.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake by FMR LLC may increase investor confidence and potentially influence trading activity.
• Management: Awareness of a large institutional holder may influence management's strategic decisions, though the filing states the stake is not for control purposes.

Key Dates

Keywords

Lantheus Holdings Inc, LANTHEUS HLDGS INC, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investment, medical diagnostics, healthcare